{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T03:39:43Z","timestamp":1782877183793,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"am","delay-in-days":304,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006451","name":"Hospices Civils de Lyon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006451","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.cca.2020.09.019","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T22:03:09Z","timestamp":1600207389000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Anti-ZnT8 autoantibodies: A new marker to be screened in patients with anti-adrenal antibodies"],"prefix":"10.1016","volume":"511","author":[{"given":"Chlo\u00e9","family":"Bost","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teoli","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dechomet","family":"Magali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fortenfant","family":"Fran\u00e7oise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Nicole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2020.09.019_b0005","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000321239","article-title":"Autoimmune Addison\u2019s disease","volume":"20","author":"Betterle","year":"2011","journal-title":"Endocr. Dev."},{"key":"10.1016\/j.cca.2020.09.019_b0010","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1530\/EJE-13-0528","article-title":"Addison\u2019s disease: A survey on 633 patients in Padova","volume":"169","author":"Betterle","year":"2013","journal-title":"Eur. J. Endocrinol."},{"issue":"12","key":"10.1016\/j.cca.2020.09.019_b0015","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s40618-019-01079-6","article-title":"Epidemiology, pathogenesis, and diagnosis of Addison\u2019s disease in adults","volume":"42","author":"Betterle","year":"2019","journal-title":"J. Endocrinol. Invest."},{"issue":"1","key":"10.1016\/j.cca.2020.09.019_b0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12020-016-0916-7","article-title":"Positive autoantibodies to ZnT8 indicate elevated risk for additional autoimmune conditions in patients with Addison\u2019s disease","volume":"53","author":"Fichna","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.cca.2020.09.019_b0025","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1373\/clinchem.2011.170662","article-title":"Diabetes antibody standardization program: First proficiency evaluation of assays for autoantibodies to zinc transporter 8","volume":"57","author":"Lampasona","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2020.09.019_b0030","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2337\/dc08-2305","article-title":"Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4","volume":"33","author":"Lampasona","year":"2010","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.cca.2020.09.019_b0035","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11892-013-0405-9","article-title":"Novel diabetes autoantibodies and prediction of type 1 diabetes","volume":"13","author":"Wenzlau","year":"2013","journal-title":"Curr. Diab. Rep."},{"issue":"1","key":"10.1016\/j.cca.2020.09.019_b0040","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1196\/annals.1447.029","article-title":"SlC30A8 Is a major target of humoral autoimmunity in type 1 diabetes and a predictive marker in prediabetes","volume":"1150","author":"Wenzlau","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cca.2020.09.019_b0045","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1210\/jc.2009-1368","article-title":"Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: Observations from a Norwegian registry","volume":"94","author":"Erichsen","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.cca.2020.09.019_b0050","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.numecd.2008.09.004","article-title":"Diabetes-linked zinc transporter ZnT8 is a homodimeric protein expressed by distinct rodent endocrine cell types in the pancreas and other glands","volume":"19","author":"Murgia","year":"2009","journal-title":"Nutrit. Metabolism Cardiovasc. Dis."},{"key":"10.1016\/j.cca.2020.09.019_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ando.2017.12.001","article-title":"SFE\/SFEDP adrenal insufficiency French consensus: Introduction and handbook Consensus sur l\u2019insuffisance surr\u00e9nale de la SFE\/SFEDP: introduction et guide","volume":"79","author":"Reznik","year":"2018","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"10.1016\/j.cca.2020.09.019_b0060","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: An endocrine society clinical practice guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.cca.2020.09.019_b0065","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/joim.12162","article-title":"Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency","volume":"275","author":"Husebye","year":"2014","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.cca.2020.09.019_b0070","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc19-S002","article-title":"2. Classification and diagnosis of diabetes: Standards of medical care in diabetes \u2013 2019","volume":"42","author":"American Diabetes Association","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2020.09.019_b0075","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/0140-6736(92)91829-W","article-title":"21-Hydroxylase, a major autoantigen in idiopathic Addison\u2019s disease","volume":"339","author":"Winqvist","year":"1992","journal-title":"Lancet (Lond., England)"},{"issue":"3","key":"10.1016\/j.cca.2020.09.019_b0080","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/clinchem\/41.3.375","article-title":"Immunoprecipitation assay for autoantibodies to steroid 21-hydroxylase in autoimmune adrenal diseases","volume":"41","author":"Colls","year":"1995","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2020.09.019_b0085","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00125-008-0967-2","article-title":"Diabetes Antibody Standardization Program: Evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2","volume":"51","author":"T\u00f6rn","year":"2008","journal-title":"Diabetologia"},{"issue":"43","key":"10.1016\/j.cca.2020.09.019_b0090","doi-asserted-by":"crossref","first-page":"17040","DOI":"10.1073\/pnas.0705894104","article-title":"The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes","volume":"104","author":"Wenzlau","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.cca.2020.09.019_b0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12020-010-9359-8","article-title":"Co-morbidities, management and clinical outcome of auto-immune Addison\u2019s disease","volume":"38","author":"Leelarathna","year":"2010","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.cca.2020.09.019_b0100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/jaut.1995.0009","article-title":"Associated autoimmunity in Addison's disease","volume":"8","author":"Zelissen","year":"1995","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.cca.2020.09.019_b0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.diabet.2018.03.003","article-title":"Very high titres of ZnT8 autoantibodies at type 1 diabetes onset and presence of autoantibodies related to other autoimmune disorders","volume":"46","author":"Marchand","year":"2020","journal-title":"Diabetes Metabolism"},{"issue":"3","key":"10.1016\/j.cca.2020.09.019_b0110","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00592-017-1091-x","article-title":"Autoantibodies against zinc transporter 8 are related to age and metabolic state in patients with newly diagnosed autoimmune diabetes","volume":"55","author":"Niechcia\u0142","year":"2018","journal-title":"Acta Diabetol."},{"issue":"8","key":"10.1016\/j.cca.2020.09.019_b0115","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/dmrr.2440","article-title":"Autoantibodies against zinc transporter 8 are related to age, metabolic state and HLA DR genotype in children with newly diagnosed type 1 diabetes: ZnT8A: Age, Metabolic State and HLA","volume":"29","author":"Salonen","year":"2013","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.cca.2020.09.019_b0120","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2337\/dc15-1027","article-title":"Positivity for zinc transporter 8 autoantibodies at diagnosis is subsequently associated with reduced b-cell function and higher exogenous insulin requirement in children and adolescents with type 1 diabetes","volume":"39","author":"Juusola","year":"2016","journal-title":"Diabetes Care"},{"issue":"1-2","key":"10.1016\/j.cca.2020.09.019_b0125","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.clinbiochem.2016.06.008","article-title":"Zinc transporter 8 autoantibodies assessment in daily practice","volume":"50","author":"Hussein","year":"2017","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2020.09.019_b0130","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cca.2017.12.043","article-title":"Screening of ZnT8 autoantibodies in the diagnosis of autoimmune diabetes in a large French cohort","volume":"478","author":"Garnier","year":"2018","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.cca.2020.09.019_b0135","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2164-5-32","article-title":"In silico identification and expression of SLC30 family genes: An expressed sequence tag data mining strategy for the characterization of zinc transporters' tissue expression","volume":"5","author":"Seve","year":"2004","journal-title":"BMC Genom."},{"issue":"20","key":"10.1016\/j.cca.2020.09.019_b0140","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1242\/jcs.03164","article-title":"In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion","volume":"119","author":"Chimienti","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.cca.2020.09.019_b0145","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/B978-0-12-394390-3.00008-2","article-title":"Molecular architecture and function of ZnT transporters","volume":"69","author":"Kambe","year":"2012","journal-title":"Curr. Top Membr."},{"key":"10.1016\/j.cca.2020.09.019_b0150","first-page":"4434","article-title":"Beta-cell autoantibodies, human leukocyte antigen II alleles, and type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy","volume":"85","author":"Gylling","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2020.09.019_b0155","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1210\/jc.2003-030279","article-title":"Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I","volume":"89","author":"S\u00f6derbergh","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2020.09.019_b0160","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1507\/endocrj.EJ12-0069","article-title":"ZnT8 and type 1 diabetes","volume":"59","author":"Kawasaki","year":"2012","journal-title":"Endocr. J."},{"key":"10.1016\/j.cca.2020.09.019_b0165","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ando.2017.10.006","article-title":"Group 3: Strategies for identifying the cause of adrenal insufficiency: diagnostic algorithms","volume":"78","author":"Proust-Lemoine","year":"2017","journal-title":"Ann. Endocrinol."},{"key":"10.1016\/j.cca.2020.09.019_b0170","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2249.1997.262-ce1153.x","article-title":"21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison\u2019s disease","volume":"107","author":"Falorni","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cca.2020.09.019_b0175","first-page":"3507","article-title":"Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison\u2019s disease","volume":"83","author":"Laureti","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120304514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120304514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:03:17Z","timestamp":1762113797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898120304514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":35,"alternative-id":["S0009898120304514"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2020.09.019","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-ZnT8 autoantibodies: A new marker to be screened in patients with anti-adrenal antibodies","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2020.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}